1.
Clin Exp Dermatol
; 47(3): 616-617, 2022 Mar.
Article
in English
| MEDLINE
| ID: mdl-34748673
ABSTRACT
A 45-year-old white woman established on risankizumab self-presented to our service with pustular psoriasis affecting 60% of her body surface area. No history of pustular psoriasis was described in the 22 years that she had been diagnosed with psoriasis. This, to our knowledge, is the first case of paradoxical pustular psoriasis associated with risankizumab.
Subject(s)
Antibodies, Monoclonal/adverse effects , Dermatologic Agents/adverse effects , Interleukin-23 Subunit p19/antagonists & inhibitors , Psoriasis/chemically induced , Cyclosporine/therapeutic use , Dermatologic Agents/therapeutic use , Disease Progression , Female , Humans , Middle Aged , Psoriasis/drug therapy , Psoriasis/pathology
2.
J Eur Acad Dermatol Venereol
; 38(2): e145-e147, 2024 Feb.
Article
in English
| MEDLINE
| ID: mdl-37705380